CTLP News - Candlesense

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035 As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning i...

How does this settlement compare to similar patent litigation outcomes for other rare‑disease drug companies and what are the broader competitive implications? What is the market's likely reaction to the news in terms of CTLP stock price volatility and volume in the short term? How will the settlement and delayed generic entry until 2035 affect Catalyst Pharmaceuticals' projected cash flows and valuation?

Lawsuits

3 days ago

CTLP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cantaloupe, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cantaloupe, Inc. (NASDAQ: CTLP) to 365 Retail Markets, LLC for $11.20 per share in cas...

Mergers

2 months ago

Shareholder Alert: The Ademi Firm Investigates Whether Cantaloupe, Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Cantaloupe (NASDAQ: CTLP) for possible breaches of fiduciary duty and other violations of law in its transaction with 365 Retail Markets....

Mergers

2 months ago

Cantaloupe, Inc. Enters into Definitive Agreement to Be Acquired by 365 Retail Markets

MALVERN, Pa. & TROY, Mich.--(BUSINESS WIRE)--Cantaloupe, Inc. (NASDAQ: CTLP) (Cantaloupe”), a global technology leader offering end-to-end technology solutions for self-service commerce, today anno...

Mergers

2 months ago